FINAL RESULTS FROM AIPAC: A PHASE IIB COMPARING EFTILAGIMOD ALPHA (A SOLUBLE LAG-3 PROTEIN) VS. PLACEBO IN COMBINATION WITH WEEKLY PACLITAXEL IN HR+HER2-MBC

被引：2

作者：

Wildiers, Hans ^{[1
,2
]}

Dirix, Luc ^{[3
]}

Armstrong, Anne ^{[4
]}

De Cuypere, Eveline ^{[5
]}

Dalenc, Florence ^{[6
]}

Chan, Steven ^{[7
]}

Marme, Frederik ^{[8
]}

Schroder, Carolina Pia ^{[9
]}

Huober, Jens ^{[10
]}

Vuylsteke, Peter ^{[11
,12
]}

Jacquin, Jean-Philippe ^{[13
]}

Brain, Etienne ^{[14
]}

Kummel, Sherko ^{[15
]}

Papai, Zsuzsanna ^{[16
]}

Mueller, Christian ^{[17
]}

Brignone, Chrystelle ^{[17
]}

Triebel, Frederic ^{[17
]}

机构：

[1] Univ Hosp Leuven, Dept Gen Med Oncol, Leuven, Belgium

[2] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium

[3] GZA Ziekenhuizen Campus Sint Augustin, Oosterveldlaan, Belgium

[4] Christie NHS Fdn Trust, Manchester, Lancs, England

[5] AZ Sint Jan Brugge Oostende AV, Ruddershove, Belgium

[6] Inst Univ Canc Oncopole, Inst Claudius Regaud, Toulouse, France

[7] Nottingham Canc Clin Trials Team, Nottingham, England

[8] Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[9] Univ Med Ctr Groningen, Groningen, Netherlands

[10] Univ Klin Ulm, Ulm, Germany

[11] CMSE UCLouvain, CHU UCL NAMUR Site Ste Elisabeth, Uccle, Belgium

[12] Univ Botswana, Uccle, Belgium

[13] Inst Cancerol Loire, St Priest En Jarez, France

[14] Hop Rene Huguenin, Inst Curie, St Cloud, France

[15] KEM Evang Kliniken Essen Mitte, Essen, Germany

[16] MH Egeszsegugyi Kozpont Onkol, Budapest, Hungary

[17] Immutep, Berlin, Germany

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.948

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

948

引用

页码：A997 / A997

页数：1